Want to join the conversation?
$GILD's 3Q15 HIV revenues increased 7% YoverY to $2.9Bil as the company's Truvada-based franchise continues to hold its market leadership position. In the US revenues were more than $1.9Bil, a 16% growth YoverY. Driven by underlying prescription demand of both Stribild and Complera with YoverY growth of 44% and 14% respectively.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!